Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Pilot Study of Patient-Reported Outcomes in Stargardt Disease: Correlation With Functional and Structural Findings.
Journal: Investigative ophthalmology & visual science
Published: May 07, 2026
Association of Autosomal Dominant Snowflake Vitreoretinal Degeneration with Retinoschisis.
Journal: Ophthalmology science
Published: January 29, 2026
Short stature, optic atrophy, and Pelger-Huët anomaly (SOPH) syndrome: report of a case lacking neutrophil morphologic changes and review of literature.
Journal: Ophthalmic genetics
Published: December 03, 2025
A novel missense TUBB4B variant outside of the canonical hotspot is associated with cone-rod dystrophy and sensorineural hearing loss.
Journal: Ophthalmic genetics
Published: October 07, 2025
Addressing Challenges in Developing Treatments for Inherited Retinal Diseases: Recommendations From the Third Monaciano Symposium.
Journal: Translational vision science & technology
Published: August 27, 2025
Corrigendum to "Baseline Visual Field Findings in the RUSH2A Study: Associated Factors and Correlation With Other Measures of Disease Severity." Am J Ophthalmol. 2020; 219:87-100.
Journal: American journal of ophthalmology
Published: August 03, 2025
Ȧland Island eye disease in two patients harboring novel CACNA1F variants.
Journal: Ophthalmic genetics
Published: May 22, 2025
Corrigendum to "Baseline Visual Field Findings in the RUSH2A Study: Associated Factors and Correlation With Other Measures of Disease Severity" [Am J Ophthalmol 2020;219:87-100].
Journal: American journal of ophthalmology
Published: March 08, 2025
Impact of Dry Age-Related Macular Degeneration on Daily Activities and Quality of Life: Interview Findings From Patients and Caregivers Relative to a General Population.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: September 13, 2024
A novel large multi-gene deletion in syndromic choroideremia.
Journal: Ophthalmic genetics
Published: September 11, 2024
Subretinal Gene Therapy Drug AGTC-501 for XLRP Phase 1/2 Multicenter Study (HORIZON): 24-Month Safety and Efficacy Results.
Journal: American journal of ophthalmology
Published: May 30, 2024
Last Updated: 09/26/2026